NASDAQ:SRNE - Sorrento Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$2.22 -0.04 (-1.77 %)
(As of 02/21/2019 04:49 AM ET)
Previous Close$2.26
Today's Range$2.18 - $2.25
52-Week Range$1.95 - $10.65
Volume841,900 shs
Average Volume1.32 million shs
Market Capitalization$271.46 million
P/E Ratio17.08
Dividend YieldN/A
Beta2.51

Analyst Ratings

Sorrento Therapeutics (NASDAQ:SRNE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Sorrento Therapeutics in the last 12 months. Their average twelve-month price target is $21.4167, suggesting that the stock has a possible upside of 864.71%. The high price target for SRNE is $40.00 and the low price target for SRNE is $10.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $21.4167$14.75$21.4167$21.0833
Price Target Upside: 864.71% upside599.05% upside483.56% upside290.43% upside

Sorrento Therapeutics (NASDAQ:SRNE) Consensus Price Target History

Price Target History for Sorrento Therapeutics (NASDAQ:SRNE)

Sorrento Therapeutics (NASDAQ:SRNE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/23/2019HC WainwrightSet Price TargetBuy$40.00HighView Rating Details
11/12/2018OppenheimerSet Price TargetBuy$10.00MediumView Rating Details
6/28/2018B. RileyInitiated CoverageBuy$14.25MediumView Rating Details
8/3/2017Roth CapitalInitiated CoverageBuy$7.00HighView Rating Details
8/3/2017UBS GroupInitiated CoverageOutperform$7.00HighView Rating Details
6/17/2017FBR & CoReiterated RatingBuyLowView Rating Details
5/22/2017Rodman & RenshawLower Price TargetBuy ➝ Buy$30.00 ➝ $20.00HighView Rating Details
(Data available from 2/21/2017 forward)
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel